跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RUKOBIA 600 MG COMPRIMIDOS DE LIBERACION PROLONGADA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
RUKOBIA 600 MG COMPRIMIDOS DE LIBERACION PROLONGADA
Approved
STANDARD
RUKOBIA 600 MG COMPRIMIDOS DE LIBERACION PROLONGADA
Viiv Healthcare B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Feb 25, 2021
Approval ID
7bb5220cbbc4ce03
Company
Viiv Healthcare B.V.
Type
Standard
Approval Details
Approval Id
7bb5220cbbc4ce03
Drug Cima Aemps Name
RUKOBIA 600 MG COMPRIMIDOS DE LIBERACION PROLONGADA
Register Number
1201518001
Holder Company Name
Viiv Healthcare B.V.
Marketing Company Name
Laboratorios Viiv Healthcare S.L.
Holder Company Detail Path
/organization/viiv-healthcare-bv
Authorization Date
2021-02-25
Dosage Form
COMPRIMIDO DE LIBERACIÓN PROLONGADA
Dose
600 mg
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
Yes
Company Name
Viiv Healthcare B.V.
Company Detail Path
/organization/viiv-healthcare-bv
Company Information
Pharmaceutical Company Name
ViiV Healthcare BV
Country Name
Netherlands
Website
http://viivhealthcare.com/nl-nl
Active Ingredients
FOSTEMSAVIR TROMETAMOL
724,56 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Feb 25, 2021
Approval ID
7bb5220cbbc4ce03
Type
Standard
Back to CIMA-AEMPS Approvals
